doi: 10.3109/08830185.2013.774391 243 SastreJ.PallardoF
For a 250-pound person, closer to 15
Across SELECT, STEPlike trials, pediatric obesity studies, and ESSENCE, Wegovy demonstrates robust, durable weight loss, clinically meaningful CV risk reduction, and promising liver histologic responses, albeit with an established GIdominant tolerability profile and specific but manageable safety concerns
Other Ingredients:Glycerin, medium-chain triglycerides, phospholipids (soy), natural flavor
Cross-reactivity with standard immunoassays for THC, opioids, amphetamines, cocaine, and other targets is not documented and is biologically implausible
Conseils de conservation et d'utilisation Conserver au frais et au sec